Functional Dichotomy between OX40 and 4-1BB in Modulating Effector CD8 T Cell Responses1

Members of the TNFR family are thought to deliver costimulatory signals to T cells and modulate their function and survival. In this study, we compare the role of two closely related TNFR family molecules, OX40 and 4-1BB, in generating effector CD8 T cells to Ag delivered by adenovirus. OX40 and 4-1BB were both induced on responding naive CD8 T cells, but 4-1BB exhibited faster and more sustained kinetics than OX40. OX40-deficient CD8 T cells initially expanded normally; however, their accumulation and survival at late times in the primary response was significantly impaired. In contrast, 4-1BB-deficient CD8 T cells displayed hyperresponsiveness, expanding more than wild-type cells. The 4-1BB-deficient CD8 T cells also showed enhanced maturation attributes, whereas OX40-deficient CD8 T cells had multiple defects in the expression of effector cell surface markers, the synthesis of cytokines, and in cytotoxic activity. These results suggest that, in contrast to current ideas, OX40 and 4-1BB can have a clear functional dichotomy in modulating effector CD8 T cell responses. OX40 can positively regulate effector function and late accumulation/survival, whereas 4-1BB can initially operate in a negative manner to limit primary CD8 responses.

[1]  B. Kwon,et al.  Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor. , 2005, Blood.

[2]  M. Ostrowski,et al.  Enhancement of HIV-Specific CD8 T Cell Responses by Dual Costimulation with CD80 and CD137L1 , 2005, The Journal of Immunology.

[3]  Yu Wang,et al.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand , 2005, The Journal of experimental medicine.

[4]  Tomoko Yamaguchi,et al.  Engagement of 4-1BB Inhibits the Development of Experimental Allergic Conjunctivitis in Mice1 , 2005, The Journal of Immunology.

[5]  M. Croft,et al.  OX40 and Bcl-xL Promote the Persistence of CD8 T Cells to Recall Tumor-Associated Antigen1 , 2005, The Journal of Immunology.

[6]  D. Kelvin,et al.  The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. , 2005, Blood.

[7]  B. Kwon,et al.  4-1BB (CD137) Is Required for Rapid Clearance of Listeria monocytogenes Infection , 2005, Infection and Immunity.

[8]  K. Sugamura,et al.  During Viral Infection of the Respiratory Tract, CD27, 4-1BB, and OX40 Collectively Determine Formation of CD8+ Memory T Cells and Their Capacity for Secondary Expansion1 , 2005, The Journal of Immunology.

[9]  yang-xin fu,et al.  Regulation of Follicular Dendritic Cell Networks by Activated T Cells: The Role of CD137 Signaling1 , 2005, The Journal of Immunology.

[10]  B. Kwon,et al.  Enhanced CD4 T Cell Responsiveness in the Absence of 4-1BB1 , 2005, The Journal of Immunology.

[11]  M. Croft The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA. , 2005, Trends in immunology.

[12]  B. Dörken,et al.  Costimulation by CD137/4–1BB inhibits T cell apoptosis and induces Bcl‐xL and c‐FLIPshort via phosphatidylinositol 3‐kinase and AKT/protein kinase B , 2005, European journal of immunology.

[13]  B. Kwon,et al.  Stimulation with 4-1BB (CD137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD4+ T cells. , 2005, Blood.

[14]  K. Pfeffer,et al.  The role of herpesvirus entry mediator as a negative regulator of T cell-mediated responses. , 2005, The Journal of clinical investigation.

[15]  Wenjun Ouyang,et al.  A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Sharpe,et al.  4-1BB and OX40 Act Independently to Facilitate Robust CD8 and CD4 Recall Responses1 , 2004, The Journal of Immunology.

[17]  Graham M Lord,et al.  Recent developments in the transcriptional regulation of cytolytic effector cells , 2004, Nature Reviews Immunology.

[18]  Hye-young Park,et al.  4-1BB-mediated immunotherapy of rheumatoid arthritis , 2004, Nature Medicine.

[19]  J. Bae,et al.  CD137-Deficient Mice Have Reduced NK/NKT Cell Numbers and Function, Are Resistant to Lipopolysaccharide-Induced Shock Syndromes, and Have Lower IL-4 Responses1 , 2004, The Journal of Immunology.

[20]  Zihai Li,et al.  4-1BB and OX40 Dual Costimulation Synergistically Stimulate Primary Specific CD8 T Cells for Robust Effector Function1 , 2004, The Journal of Immunology.

[21]  Aoshuang Chen,et al.  The 4-1BB Costimulation Augments the Proliferation of CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.

[22]  Lieping Chen Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity , 2004, Nature Reviews Immunology.

[23]  M. Croft,et al.  Costimulation of CD8 T Cell Responses by OX401 , 2004, The Journal of Immunology.

[24]  P. Rogers,et al.  The costimulation-regulated duration of PKB activation controls T cell longevity , 2004, Nature Immunology.

[25]  E. Bertram,et al.  A Switch in Costimulation from CD28 to 4-1BB during Primary versus Secondary CD8 T Cell Response to Influenza In Vivo1 , 2004, The Journal of Immunology.

[26]  E. Wherry,et al.  Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells , 2003, Nature Immunology.

[27]  I. Humphreys,et al.  A Critical Role for OX40 in T Cell–mediated Immunopathology during Lung Viral Infection , 2003, The Journal of experimental medicine.

[28]  D. Tough,et al.  IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells , 2003, The Journal of Immunology.

[29]  M. Croft Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? , 2003, Nature Reviews Immunology.

[30]  J. Allison,et al.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 , 2003, Nature Immunology.

[31]  M. McCausland,et al.  CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice. , 2003, The Journal of clinical investigation.

[32]  D. Tough,et al.  IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells1 , 2003, The Journal of Immunology.

[33]  C. Takahashi,et al.  Effector CD8 T cells possess suppressor function after 4-1BB and Toll-like receptor triggering , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[35]  Urs Christen,et al.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes , 2003, Nature.

[36]  R. Ahmed,et al.  Role of CD4 T Cell Help and Costimulation in CD8 T Cell Responses During Listeria monocytogenes Infection 1 , 2003, The Journal of Immunology.

[37]  Susan M. Kaech,et al.  Molecular and Functional Profiling of Memory CD8 T Cell Differentiation , 2002, Cell.

[38]  Lieping Chen,et al.  Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease , 2002, Nature Medicine.

[39]  Sujung Park,et al.  4-1BB Promotes the Survival of CD8+ T Lymphocytes by Increasing Expression of Bcl-xL and Bfl-11 , 2002, The Journal of Immunology.

[40]  Lieping Chen,et al.  Signaling Through NK Cell-Associated CD137 Promotes Both Helper Function for CD8+ Cytolytic T Cells and Responsiveness to IL-2 But Not Cytolytic Activity1 , 2002, The Journal of Immunology.

[41]  Z. Lee,et al.  Immune Responses in 4-1BB (CD137)-Deficient Mice1 , 2002, The Journal of Immunology.

[42]  Lieping Chen,et al.  Cutting Edge: Expression of Functional CD137 Receptor by Dendritic Cells1 , 2002, The Journal of Immunology.

[43]  E. Bertram,et al.  Temporal Segregation of 4-1BB Versus CD28-Mediated Costimulation: 4-1BB Ligand Influences T Cell Numbers Late in the Primary Response and Regulates the Size of the T Cell Memory Response Following Influenza Infection1 , 2002, The Journal of Immunology.

[44]  D. Richman,et al.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.

[45]  K. Takeda,et al.  Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells. , 2002, International immunology.

[46]  Aaron J. Johnson,et al.  Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. , 2002, The Journal of clinical investigation.

[47]  Lieping Chen,et al.  Administration of Agonistic Anti-4-1BB Monoclonal Antibody Leads to the Amelioration of Experimental Autoimmune Encephalomyelitis1 , 2002, The Journal of Immunology.

[48]  G. Freeman,et al.  The B7–CD28 superfamily , 2002, Nature Reviews Immunology.

[49]  C. Maliszewski,et al.  Ox40 Costimulation Enhances the Development of T Cell Responses Induced by Dendritic Cells In Vivo , 2002, The Journal of Immunology.

[50]  C. Thompson,et al.  T-cell regulation by CD28 and CTLA-4 , 2001, Nature Reviews Immunology.

[51]  P. Rogers,et al.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. , 2001, Immunity.

[52]  M. Debenedette,et al.  4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy1 , 2001, The Journal of Immunology.

[53]  A. Weinberg,et al.  Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth. , 2000, Cancer research.

[54]  T. Noda,et al.  Impairment of Antigen-Presenting Cell Function in Mice Lacking Expression of Ox40 Ligand , 2000, The Journal of experimental medicine.

[55]  M. Bachmann,et al.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. , 1999, Immunity.

[56]  G. Freeman,et al.  Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.

[57]  R. Mittler,et al.  Anti–4-1bb Monoclonal Antibodies Abrogate T Cell–Dependent Humoral Immune Responses in Vivo through the Induction of Helper T Cell Anergy , 1999, The Journal of experimental medicine.

[58]  R. Ahmed,et al.  4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. , 1999, Journal of immunology.

[59]  D. A. Carlow,et al.  A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation. , 1999, Journal of immunology.

[60]  Lieping Chen,et al.  NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodies. , 1998, Cellular immunology.

[61]  S Oehen,et al.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.

[62]  S. Kim,et al.  Human 4-1BB (CD137) signals are mediated by TRAF2 and activate nuclear factor-kappa B. , 1998, Biochemical and biophysical research communications.

[63]  C. Thompson,et al.  4-1BB and Ox40 Are Members of a Tumor Necrosis Factor (TNF)-Nerve Growth Factor Receptor Subfamily That Bind TNF Receptor-Associated Factors and Activate Nuclear Factor κB , 1998, Molecular and Cellular Biology.

[64]  M. Rep,et al.  Phenotypic and Functional Separation of Memory and Effector Human CD8+ T Cells , 1997, The Journal of experimental medicine.

[65]  A. Aruffo,et al.  4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses , 1997, The Journal of experimental medicine.

[66]  Lieping Chen,et al.  Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors , 1997, Nature Medicine.

[67]  J. Bonner,et al.  Differentiation , 1968, Nature.

[68]  C. Ware,et al.  B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator , 2005, Nature Immunology.

[69]  T. Watts,et al.  TNF/TNFR family members in costimulation of T cell responses. , 2005, Annual review of immunology.

[70]  C. Ware Network communications: lymphotoxins, LIGHT, and TNF. , 2005, Annual review of immunology.

[71]  J. Altman,et al.  In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses , 2002, Nature Immunology.